Anebulo Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Jun 2020 | $223.9K | $3.0M | $3.0M |
| Mar 2021 | $10.8M | $4.3M | $3.3M |
| Jun 2021 | $241.6K | $21.7M | — |
| Sep 2021 | $607.7K | $20.5M | — |
| Dec 2021 | $49.9K | $19.0M | — |
| Mar 2022 | $85.8K | $17.2M | — |
| Jun 2022 | $512.5K | $15.6M | — |
| Sep 2022 | $698.2K | $19.8M | — |
| Dec 2022 | $1.4M | $16.9M | — |
| Mar 2023 | $1.5M | $14.4M | — |
| Jun 2023 | $1.1M | $11.7M | $11.2M |
| Sep 2023 | $716.6K | $9.0M | $8.5M |
| Dec 2023 | $1.0M | $7.5M | $6.6M |
| Mar 2024 | $1.0M | $6.0M | $5.1M |
| Jun 2024 | $260.6K | $4.1M | $3.1M |
| Sep 2024 | $569.2K | $2.5M | $1.4M |
| Dec 2024 | $878.8K | $15.8M | $15.0M |
| Mar 2025 | $546.0K | $14.0M | $13.3M |
| Jun 2025 | $487.7K | $12.1M | $11.6M |
| Sep 2025 | $963.8K | $10.7M | $10.4M |
| Dec 2025 | $1.5M | $9.4M | $9.0M |